The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Pfizer and Merck & Co have filed their diabetes drug ertugliflozin in the US and EU, and the companies hope their alliance will make an impact in the crowded diabetes drug market. The drug is an ...

Merck Foundation Song Awards “Diabetes and Hy­pertension” to promote healthy lifestyle and raise awareness about prevention of Diabetes and Hyperten­sion and healthy lifestyle promotion in Africa.

Merck & Co. managed to increase revenues by ... Sales of its biggest earner, diabetes franchise Januvia/Janumet also declined 3% to $5.89 billion because of growing price pressure and newer ...

as well as its diabetes franchise. However, this decline, in my opinion, is not critical for Merck's financial position, since sales of Januvia and Janumet account for only 3.1% of its total revenue.

Merck is recognized for its extensive product portfolio covering treatments in areas like oncology, diabetes, cardiovascular diseases, vaccines, and infectious diseases. The company also operates ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...